Age–period–cohort analysis of asthma, allergic rhinitis, and atopic dermatitis prevalence in Japan
Tasuku Okui
Environ Anal Health Toxicol. 2020;35(3):e2020012 Published online 2020 Jul 16 DOI: https://doi.org/10.5620/eaht.2020012
Citations to this article as recorded by 
Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis
Theo Gulen
Immunology and Allergy Clinics of North America.2023; 43(4): 681. CrossRef
Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
Zhufeng Wang, Yun Li, Yi Gao, Yu Fu, Junfeng Lin, Xuedong Lei, Jinping Zheng, Mei Jiang
Respiratory Research.2023;[Epub] CrossRef
A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
Theo Gülen
Diagnostics.2023; 13(21): 3307. CrossRef
Trends and age-period-cohort effects on incidence and mortality of asthma in Sichuan Province, China, 1990–2019
Yu Luo, Mu Wang, Yumei Tian
BMC Pulmonary Medicine.2022;[Epub] CrossRef
Dupilumab pharmacokinetics in Chinese healthy subjects and patients with atopic dermatitis: Results of two randomized, double-blind, placebo-controlled studies
Pierre-François Clot, Mohamed Kamal, Jing Sun, Christine Xu, Fangyuan Kong, Yongzhen Gu, Na Yang, WeiHong Yin, Bing Chen, Jeffrey E. Ming, Yaozong Yuan
International Immunopharmacology.2021; 99: 107985. CrossRef